Defucosylated Monoclonal Antibody (H(2)Mab-139-mG(2a)-f) Exerted Antitumor Activities in Mouse Xenograft Models of Breast Cancers against Human Epidermal Growth Factor Receptor 2

por Suzuki, Hiroyuki, Ohishi, Tomokazu, Nanamiya, Ren, Kawada, Manabu, Kaneko, Mika K., Kato, Yukinari
Publicado 2023

EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer

por Nanamiya, Ren, Saito-Koyama, Ryoko, Miki, Yasuhiro, Inoue, Chihiro, Asavasupreechar, Teeranut, Abe, Jiro, Sato, Ikuro, Sasano, Hironobu
Publicado 2021

The correlation of p22(phox) and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma

por Kobayashi, Masayuki, Saito, Ryoko, Miki, Yasuhiro, Nanamiya, Ren, Inoue, Chihiro, Abe, Jiro, Sato, Ikuro, Okada, Yoshinori, Sasano, Hironobu
Publicado 2019

11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma

por Saito, Ryoko, Miki, Yasuhiro, Abe, Takuto, Miyauchi, Eisaku, Abe, Jiro, Nanamiya, Ren, Inoue, Chihiro, Sato, Ikuro, Sasano, Hironobu
Publicado 2020

An anti-TROP2 monoclonal antibody TrMab-6 exerts antitumor activity in breast cancer mouse xenograft models

por Tanaka, Tomohiro, Ohishi, Tomokazu, Asano, Teizo, Takei, Junko, Nanamiya, Ren, Hosono, Hideki, Sano, Masato, Harada, Hiroyuki, Kawada, Manabu, Kaneko, Mika K., Kato, Yukinari
Publicado 2021

Anti-HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma

por Asano, Teizo, Ohishi, Tomokazu, Takei, Junko, Nakamura, Takuro, Nanamiya, Ren, Hosono, Hideki, Tanaka, Tomohiro, Sano, Masato, Harada, Hiroyuki, Kawada, Manabu, Kaneko, Mika K., Kato, Yukinari
Publicado 2021